Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.43 +0.13 (+10.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Other Accumulated Expenses (2017 - 2025)

Updated

Chemomab Therapeutics (CMMB) reported Other Accumulated Expenses of $18,000 for Q2 2025.

Analysis

Chemomab Therapeutics (CMMB) Other Accumulated Expenses (2017 - 2025) Analysis & Trends

At the end of FY2019, Chemomab Therapeutics posted Other Accumulated Expenses of $2.3 million, up 34.6% from FY2018.

  • By year, Other Accumulated Expenses came in at $1.71 million in FY2018 (-28.3%) and $2.38 million in FY2017.
  • The Q2 2025 figure ranks as the highest quarterly Other Accumulated Expenses since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Chemomab Therapeutics 10.28 Mn 10.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 18,000.00
Dec 31, 2019 2.30 Mn
Sep 30, 2019 3.75 Mn
Jun 30, 2019 1.62 Mn
Dec 31, 2018 1.71 Mn
Dec 31, 2017 2.38 Mn
API Access

Chemomab Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY